Page 2048 - Williams Hematology ( PDFDrive )

2022 Part XII: Hemostasis and Thrombosis Chapter 117: Thrombocytopenia 2023

320. Burrows RF, Kelton JG: Fetal thrombocytopenia and its relation to maternal thrombo- 356. Peterson JA, McFarland JG, Curtis BR, Aster RH: Neonatal alloimmune thrombocy-
cytopenia. N Engl J Med 329:1463–1466, 1993. topenia: Pathogenesis, diagnosis and management. Br J Haematol 161:3–14, 2013.
321. McCrae KR, Samuels P, Schreiber AD: Pregnancy-associated thrombocytopenia: 357. Mueller-Eckhardt C, Kiefel V, Grubert A, et al: 348 Cases of suspected neonatal alloim-
Pathogenesis and management. Blood 80:2697–2714, 1992. mune thrombocytopenia. Lancet 1:363–366, 1989.
322. Bussel JB: Immune thrombocytopenia in pregnancy: Autoimmune and alloimmune. J 358. Grainger JD, Morrell G, Yates J, Deleacy D: Neonatal alloimmune thrombocytopenia
Reprod Immunol 37:35–61, 1997. with significant HLA antibodies. Arch Dis Child Fetal Neonatal Ed 86:F200–F201, 2002.
323. Shehata N, Burrows R, Kelton JG: Gestational thrombocytopenia. Clin Obstet Gynecol 359. Chow MP, Sun KJ, Yung CH, et al: Neonatal alloimmune thrombocytopenia due to
42:327–334, 1999. HLA-A2 antibody. Acta Haematol 87:153–155, 1992.
324. Kaplan C, Forestier F, Dreyfus M, et al: Maternal thrombocytopenia during pregnancy: 360. Davoren A, McParland P, Crowley J, et al: Antenatal screening for human platelet anti-
Diagnosis and etiology. Semin Thromb Hemost 21:85–94, 1995. gen-1a: Results of a prospective study at a large maternity hospital in Ireland. BJOG
325. Boehlen F, Hohlfeld P, Extermann P, et al: Platelet count at term pregnancy: A reap- 110:492–496, 2003.
praisal of the threshold. Obstet Gynecol 95:29–33, 2000. 361. Williamson LM, Hackett G, Rennie J, et al: The natural history of fetomaternal allo-
326. Ostensen M, Forger F: How safe are anti-rheumatic drugs during pregnancy. Curr Opin immunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by
Pharmacol 13:470–475, 2015. antenatal screening. Blood 92:2280–2287, 1998.
327. Chakravarty EF, Murray ER, Kelman A, Farmer P: Pregnancy outcomes after maternal 362. Jolly MC, Letsky EA, Fisk NM: The management of fetal alloimmune thrombocytope-
exposure to rituximab. Blood 117:1499–1506, 2011. nia. Prenat Diagn 22:96–98, 2002.
328. Cheng G: Eltrombopag a thrombopoietin-receptor agonist in the treatment of adult 363. Murphy MF, Hambley H, Nicolaides K, Waters AH: Severe fetomaternal alloimmune
chronic immune thrombocytopenia: A review of the efficacy and safety profile. Ther thrombocytopenia presenting with fetal hydrocephalus. Prenat Diagn 16:1152–1155,
Adv Hematol 3:155–164, 2012. 1996.
329. al-Mofada SM, Osman ME, Kides E, et al: Risk of thrombocytopenia in the infants of 364. Kaplan C, Murphy MF, Kroll H, Waters AH: Feto-maternal alloimmune thrombocy-
mothers with idiopathic thrombocytopenia. Am J Perinatol 11:423–426, 1994. topenia: Antenatal therapy with IvIgG and steroids—More questions than answers.
330. Gill KK, Kelton JG: Management of idiopathic thrombocytopenic purpura in preg- European Working Group on FMAIT. Br J Haematol 100:62–65, 1998.
nancy. Semin Hematol 37:275–289, 2000. 365. Ouwehand WH, Smith G, Ranasinghe E: Management of severe alloimmune thrombo-
331. Webert KE, Mittal R, Sigouin C, et al: A retrospective 11-year analysis of obstetric cytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 82:F173–F175, 2000.
patients with idiopathic thrombocytopenic purpura. Blood 102:4306–4311, 2003. 366. Bertrand G, Kaplan C: How do we treat fetal and neonatal alloimmune thrombocytope-
332. Stamilio DM, Macones GA: Selection of delivery method in pregnancies complicated nia? Transfusion 54:1698–1703, 2014.
by autoimmune thrombocytopenia: A decision analysis. Obstet Gynecol 94:41–47, 1999. 367. Le Toricllec E, Chenet C, Kaplan C: Safe fetal platelet genotyping: New developments.
333. Christiaens GC, Nieuwenhuis HK, Bussel JB: Comparison of platelet counts in first and Transfusion 53:1755–1762, 2013.
second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 368. Porcelijn L, Kanhai HH: Fetal thrombocytopenia. Curr Opin Obstet Gynecol 10:117–122,
90:546–552, 1997. 1998.
334. Moise KJ Jr, Cotton DB: Discordant fetal platelet counts in a twin gestation complicated 369. Weiner E, Zosmer N, Bajoria R, et al: Direct fetal administration of immunoglobulins:
by idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 156:1141–1142, 1987. Another disappointing therapy in alloimmune thrombocytopenia. Fetal Diagn Ther
335. Mushambi MC, Halligan AW, Williamson K: Recent developments in the pathophysi- 9:159–164, 1994.
ology and management of pre-eclampsia. Br J Anaesth 76:133–148, 1996. 370. Aster RH: Platelet sequestration studies in man. Br J Haematol 22:259–263, 1972.
336. Leitch CR, Cameron AD, Walker JJ: The changing pattern of eclampsia over a 60-year 371. Wadenvik H, Denfors I, Kutti J: Splenic blood flow and intrasplenic platelet kinetics in
period. Br J Obstet Gynaecol 104:917–922, 1997. relation to spleen volume. Br J Haematol 67:181–185, 1987.
337. Thomas SV: Neurological aspects of eclampsia. J Neurol Sci 155:37–43, 1998. 372. Heyns AD, Badenhorst PN, Lotter MG, et al: Kinetics and mobilization from the spleen
338. Silver RM, Branch DW, Scott JR: Maternal thrombocytopenia in pregnancy: Time for a of indium-111-labeled platelets during platelet apheresis. Transfusion 25:215–218,
reassessment. Am J Obstet Gynecol 173:479–482, 1995. 1985.
339. McCrae KR: Thrombocytopenia in pregnancy: Differential diagnosis, pathogenesis, 373. Lawrence SP, Lezotte DC, Durham JD, et al: Course of thrombocytopenia of chronic
and management. Blood Rev 17:7–14, 2003. liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospec-
340. Schlembach D: Pre-eclampsia—Still a disease of theories. Fukushima J Med Sci 49:69– tive analysis. Dig Dis Sci 40:1575–1580, 1995.
115, 2003. 374. Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 13:317–323, 2001.
341. Brittain PC, Bayliss P: Partial hydatidiform molar pregnancy presenting with severe 375. Eichner ER: Splenic function: Normal, too much and too little. Am J Med 66:311–320,
preeclampsia prior to twenty weeks gestation: A case report and review of the literature. 1979.
Mil Med 160:42–44, 1995. 376. Jacob HS: Hypersplenism: Mechanisms and management. Br J Haematol 27:1–5, 1974.
342. Luttun A, Carmeliet P: Soluble VEGF receptor Flt1: The elusive preeclampsia factor 377. Cooney DP, Smith BA: The pathophysiology of hypersplenic thrombocytopenia. Arch
discovered? J Clin Invest 111:600–602, 2003. Intern Med 121:332–337, 1968.
343. Torry DS, Hinrichs M, Torry RJ: Determinants of placental vascularity. Am J Reprod 378. McCormick PA, Murphy KM: Splenomegaly, hypersplenism and coagulation abnor-
Immunol 51:257–268, 2004. malities in liver disease. Baillieres Best Pract Res Clin Gastroenterol 14:1009–1031, 2000.
344. Maynard SE, Min JY, Merchan J, et al: Excess placental soluble fms-like tyrosine kinase 379. Sihler KC, Napolitano LM: Massive transfusion: New insights. Chest 136:1654–1667,
1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in 2009.
preeclampsia. J Clin Invest 111:649–658, 2003. 380. Hiippala ST, Myllyla GJ, Vahtera EM: Hemostatic factors and replacement of major
345. Vuorela P, Helske S, Hornig C, et al: Amniotic fluid—Soluble vascular endothelial blood loss with plasma-poor red cell concentrates. Anesth Analg 81:360–365, 1995.
growth factor receptor-1 in preeclampsia. Obstet Gynecol 95:353–357, 2000. 381. Leslie SD, Toy PT: Laboratory hemostatic abnormalities in massively transfused
346. Zhou Y, McMaster M, Woo K, et al: Vascular endothelial growth factor ligands and patients given red blood cells and crystalloid. Am J Clin Pathol 96:770–773, 1991.
receptors that regulate human cytotrophoblast survival are dysregulated in severe 382. Hardy JF, de Moerloose P, Samama CM: The coagulopathy of massive transfusion. Vox
preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Sang 89:123–127, 2005.
Pathol 160:1405–1423, 2002. 383. Cosgriff N, Moore EE, Sauaia A, et al: Predicting life-threatening coagulopathy in the
347. Venkatesha S, Toporsian M, Lam C, et al: Soluble endoglin contributes to the pathogen- massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma
esis of preeclampsia. Nat Med 12:642–649, 2006. 42:857–861, 1997.
348. Lattuada A, Rossi E, Calzarossa C, et al: Mild to moderate reduction of a von 384. Cinat ME, Wallace WC, Nastanski F, et al: Improved survival following massive trans-
Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP fusion in patients who have undergone trauma. Arch Surg 134:964–968, 1999.
microangiopathic syndrome. Haematologica 88:1029–1034, 2003. 385. Villalobos TJ, Adelson E, Riley PA Jr, Crosby WH: A cause of the thrombocytopenia
349. Hulstein JJ, van Runnard Heimel PJ, Franx A, et al: Acute activation of the endothe- and leukopenia that occur in dogs during deep hypothermia. J Clin Invest 37:1–7, 1958.
lium results in increased levels of active von Willebrand factor in hemolysis, elevated 386. Yau TM, Carson S, Weisel RD, et al: The effect of warm heart surgery on postoperative
liver enzymes and low platelets (HELLP) syndrome. J Thromb Haemost 4:2569–2575, bleeding. J Thorac Cardiovasc Surg 103:1155–1162, 1992.
2006. 387. Pina-Cabral JM, Ribeiro-da-Silva A, Almeida-Dias A: Platelet sequestration during
350. Abildgaard U, Heimdal K: Pathogenesis of the syndrome of hemolysis, elevated liver hypothermia in dogs treated with sulphinpyrazone and ticlopidine—Reversibility
enzymes, and low platelet count (HELLP): A review. Eur J Obstet Gynecol Reprod Biol accelerated after intra-abdominal rewarming. Thromb Haemost 54:838–841, 1985.
166:117–123, 2013. 388. Hoffmeister KM, Felbinger TW, Falet H, et al: The clearance mechanism of chilled
351. Egerman RS, Sibai BM: HELLP syndrome. Clin Obstet Gynecol 42:381–389, 1999. blood platelets. Cell 112:87–97, 2003.
352. Hay JE: Liver disease in pregnancy. Hepatology 47:1067–1076, 2008. 389. Hoffmeister KM, Josefsson EC, Isaac NA, et al: Glycosylation restores survival of chilled
353. Martin JN Jr, Files JC, Blake PG, et al: Postpartum plasma exchange for atypical preec- blood platelets. Science 301:1531–1534, 2003.
lampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) 390. Reddick RL, Poole BL, Penick GD: Thrombocytopenia of hibernation. Mechanism of
syndrome. Am J Obstet Gynecol 172:1107–1125, 1995. induction and recovery. Lab Invest 28:270–278, 1973.
354. Chakravorty S, Roberts I: How I manage neonatal thrombocytopenia. Br J Haematol 391. Chan KM, Beard K: A patient with recurrent hypothermia associated with thrombocy-
156:155–162, 2011. topenia. Postgrad Med J 69:227–229, 1993.
355. Kaplan C: Alloimmune thrombocytopenia of the fetus and the newborn. Blood Rev 392. Enjolras O, Wassef M, Mazoyer E, et al: Infants with Kasabach-Merritt syndrome do not
16:69–72, 2002. have “true” hemangiomas. J Pediatr 130:631–640, 1997.

Kaushansky_chapter 117_p1993-2024.indd 2023 9/21/15 2:34 PM